Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01086930
Other study ID # SCIPA Hands-On
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date September 2009
Est. completion date September 2015

Study information

Verified date April 2021
Source University of Melbourne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Loss of hand function is one of the most devastating consequences of tetraplegia because of the severe impact on activities of daily living (ADL) and the resultant dependency on others. This multi-centre study in 78 participants will measure whether additional hand therapy provided via an electrical stimulator glove and specialised computer workstation improves hand function in people with tetraplegia.


Description:

The study is a multi-centre, assessor-blind, randomised controlled phase III trial in patients with tetraplegia (a spinal cord injury). A total of 78 participants will be randomised into two groups; 1. the experimental group and 2. the control group. The control group will receive their standard rehabilitation care, while the experimental group will receive the standard rehabilitation care plus the study treatment. The study treatment will consist of one hour of extra hand training, 5 times a week, using a specialised glove which provides electrical impulses to the patient's hand allowing them to open and close their hand. The glove will be used to play games on a specialised computer workstation which focuses on hand movement and function. The main objective of this study is to determine if the experimental treatment is more effective than standard rehabilitation care alone in participants with tetraplegia. Total study duration is 3 years, including an 18 month recruitment period, an 8-week treatment period followed by 6 month and 12 month follow up assessments. The progress of the participant's therapy during the study will be assessed by a blinded assessor (the assessor will not know which group the participants are in) using standard physiotherapy and occupational therapy assessments which focus on hand function. These involve grasping and releasing different everyday objects and performing everyday tasks as well as quality of life questionnaires.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date September 2015
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: Patients will be included if they: 1. have sustained a SCI within the preceding 6 months from time of consent 2. are currently receiving inpatient rehabilitation through one of the study sites 3. will remain in hospital for 12 weeks after initial screening as part of their standard medical/rehabilitation care 4. are 16 years of age or older and able to provide informed consent 5. have a motor complete or incomplete spinal cord injury at the neurological level of C2 to T1 (as per the International Standardised Neurological Assessment for SCI) 6. can actively flex their shoulder/s to 60 degrees 7. have reduced ability to grasp using their hands 8. are able to tolerate sufficient FES to enable one hand to grasp and release 9. have the potential to benefit from FES and ReJoyce according to the judgment of the treating therapist Exclusion Criteria: Patients will not be included if they: 1. have any other type of neurological injury affecting the target hand (e.g. brachial plexus or peripheral nerve injuries) 2. have had recent trauma or surgery to the target hand or upper limb within the last 12 months 3. have had amputation of any digits on the target hand 4. are not able to sit out of bed each day for at least 2 hours over three consecutive days 5. have extensive fixed contractures in the upper limb of the target hand preventing use of the ReJoyce 6. have severe spasticity in the target hand or upper limb preventing use of the ReJoyce 7. are unable to attend the 6-month and 1-year follow-up assessments at their treating spinal unit 8. are likely to undergo hand surgery in the target hand in the next year 9. might experience autonomic dysreflexia and/or hypotension in response to electrical stimulation 10. have any contraindications to FES, such as cardiac pacemaker, epilepsy, forearm fracture or pregnancy 11. have intracranial metal implants 12. have impaired vision and/or are unable to view a computer screen 13. have any other serious medical condition including malignancies, psychiatric, behavioural or drug-dependency problems, which are likely to influence the participant's ability to cooperate or in the opinion of the study investigator would prevent the participant from adhering to the Protocol.

Study Design


Intervention

Device:
ReJoyce Workstation
The device has two parts. A muscle-stimulator garment that incorporates a wireless-triggered stimulator cuff and an earpiece, similar to a hearing aid, that sends a radio signal to the stimulator cuff. As well as a specialised workstation known as ReJoyce, which connects to a standard computer via a USB port. This work station will allow the user to play specialised computer games focusing on hand function. The stimulator system and the ReJoyce workstation were developed by Professor Arthur Prochazka, University of Alberta, Canada and has been approved by the Canadian Standards Association.
Other:
Standard Care
All participants will continue to receive the same standard care for the hand and upper limb as typically provided by their rehabilitation units.

Locations

Country Name City State
Australia Victorian Spinal Cord Injury Service, Royal Talbot Rehabilitation Centre Kew Victoria
Australia South Australian Spinal Cord Injury Service, Hampstead Rehabilitation Centre Northfield South Australia
Australia Spinal Unit, Prince of Wales Hospital Randwick New South Wales
Australia Sir George Bebrook Spinal Injuries Centre, Royal Perth Hospital Shenton Park Western Australia
Australia Royal Rehabilitation Centre Sydney Sydney New South Wales
Australia Queensland Spinal Cord Injury Service, Princess Alexandra Hospital Woolloongabba Queensland
New Zealand Burwood Academy Christchurch

Sponsors (8)

Lead Sponsor Collaborator
University of Melbourne Austin Hospital, Melbourne Australia, Burwood Hospital, Christchurch, New Zealand, Hampstead Rehabilitation Centre Adelaide, Prince of Wales Hospital, Sydney, Princess Alexandra Hospital, Brisbane, Australia, Royal Rehabilitation Centre Sydney, Shenton Park Rehabilitation Centre Perth

Countries where clinical trial is conducted

Australia,  New Zealand, 

References & Publications (2)

Harvey LA, Dunlop SA, Churilov L, Galea MP; Spinal Cord Injury Physical Activity (SCIPA) Hands On Trial Collaborators. Early intensive hand rehabilitation is not more effective than usual care plus one-to-one hand therapy in people with sub-acute spinal c — View Citation

Harvey LA, Dunlop SA, Churilov L, Hsueh YS, Galea MP. Early intensive hand rehabilitation after spinal cord injury ("Hands On"): a protocol for a randomised controlled trial. Trials. 2011 Jan 17;12:14. doi: 10.1186/1745-6215-12-14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Action Research Arm Test A standardized measure of unilateral hand and upper limb function 8 weeks and 26 weeks
Secondary Summed Upper Limb Strength of the Graded and Redefined Assessment of Strength Sensibility and Prehension Summed strength score of 10 upper limb muscles 8 weeks and 26 weeks
Secondary Sensory Score on ISNCSCI Scores for light touch and pinprick tested in dermatomes of the upper limb 8 weeks and 26 weeks
Secondary AsTex Sensory Test A measure of texture discrimination in the fingertips 8 weeks and 26 weeks
Secondary AuSpinal Test A test of hand function 8 weeks and 26 weeks
Secondary Capabilities of Upper Extremity A questionnaire about upper limb function 8 weeks and 26 weeks
Secondary Assessment of Quality of Life (AQoL) A questionnaire to assess quality of life 8 weeks and 26 weeks
Secondary Health Utilities Index Mark 3 A questionnaire to assess quality of life, but includes a domain on hand function 8 weeks and 24 weeks
Secondary Self-care subscale of the Spinal Cord Independence Measure A questionnaire about independence in self-care 8 weeks and 24 weeks
Secondary Goal Attainment Scale An assessment of whether a participant achieved pre-set goals 8 weeks
Secondary Participant Perception of Treatment Effectiveness Self resport of treatment effectiveness 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT02574572 - Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury Phase 1
Recruiting NCT05941819 - ARC Therapy to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury N/A
Completed NCT05265377 - Safety and Usability of the STELO Exoskeleton in People With Acquired Brain Injury and Spinal Cord Injury N/A
Recruiting NCT02331979 - Improving Bladder Function in SCI by Neuromodulation N/A
Completed NCT02777281 - Safe and Effective Shoulder Exercise Training in Manual Wheelchair Users With SCI N/A
Recruiting NCT02978638 - Electrical Stimulation for Continence After Spinal Cord Injury N/A
Completed NCT02161913 - Comparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their Caregivers N/A
Completed NCT02262234 - Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study Phase 1/Phase 2
Withdrawn NCT02237547 - Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury Phase 1/Phase 2
Terminated NCT02080039 - Electrical Stimulation of Denervated Muscles After Spinal Cord Injury N/A
Completed NCT01884662 - Virtual Walking for Neuropathic Pain in Spinal Cord Injury N/A
Completed NCT01642901 - Zoledronic Acid in Acute Spinal Cord Injury Phase 3
Completed NCT01471613 - Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury Phase 1/Phase 2
Terminated NCT01433159 - Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury Phase 2
Completed NCT01467817 - Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI) N/A
Completed NCT02149511 - Longitudinal Morphometric Changes Following SCI
Terminated NCT01005615 - Patterned Functional Electrical Stimulation (FES) Ergometry of Arm and Shoulder in Individuals With Spinal Cord Injury Phase 1/Phase 2
Completed NCT01025609 - Dietary Patterns and Cardiovascular (CVD) Risk in Spinal Cord Injury (SCI) Factors In Individuals With Chronic Spinal Cord Injury
Completed NCT00663663 - Telephone Intervention for Pain Study (TIPS) N/A
Completed NCT00860951 - P300 Brain Computer Interface Keyboard to Operate Assistive Technology Phase 1/Phase 2